Skip to main content
Premium Trial:

Request an Annual Quote

Biolog Granted $250,000 SBIR for Phenotype MicroArray Platform

NEW YORK, June 9 - Biolog has received a Phase I Small Business Innovation Research grant of $250,000 from the National Cancer Institute for a project using its Phenotype MicroArray assay platform in toxicological cell-based assays, the company said today.

 

The grant will support development of the technology for use with human and mouse cell lines. It is currently used with bacteria, yeast, and filamentous fungi.

 

According to Biolog, the technology can be used to determine the effect of genetic changes on cells and to determine the effect of drugs on cells.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.